CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
June 2015—Dako, an Agilent Technologies Company, announced a new master collaboration agreement with Amgen. The expanded collaboration will allow both companies to benefit from knowledge sharing within the field of drug-diagnostic research and development and in relation to companion diagnostic products.
“Together we will continue our work in the development of high-quality companion diagnostic products to enable physicians and pathologists to identify cancer patients who are more likely to respond to a specific therapy,” said Jacob Thaysen, president of Agilent’s diagnostics and genomics group.
Financial details of the agreement were not disclosed.
Dako, +45 29336980